Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE22-01-2015
22-01-2015
Shareholding Pattern For December 31, 2014
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on December 31, 2014.22-01-2015
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
R Vijayalakshmi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE08-01-2015
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Orchid Health Care Private Limited has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201129-12-2014
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
Orchid Health Care Private Limited has submitted the disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 201129-12-2014
Outcome of Allotment Committee Meeting
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Allotment Committee of the Board of Directors at their meeting held on December 22, 2014 has allotted 1,48,09,801 equity shares of Rs. 10/- each @ Rs. 49.79/- (including a premium of Rs. 39.79/- per share) as the first tranche to the Promoter group Company M/s Orchid Healthcare Private Limited on Preferential Basis as per the Corporate Debt Restructuring (CDR) Scheme approved by the CDR Empowered Group in terms of CDR Scheme.22-12-2014
Allotment Committee Meeting on Dec 22, 2014
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that a meeting of the Allotment Committee of the Board of Directors is proposed to be held on December 22, 2014 to allot shares on Preferential Basis to Orchid Healthcare Private Limited.18-12-2014
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE08-12-2014
Outcome of Board Meeting
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that Industrial Development Bank of India has withdrawn the nomination of Shri T. A. Ganesh and instead nominated Shri Nagaraj Garla, Chief General Manager and Zonal Head, IDBI Bank Ltd, Chennai as its nominee. He was appointed as a Nominee Director of Orchid Chemicals & Pharmaceuticals Limited at the Board meeting held on November 13, 2014.14-11-2014
Financial Results with Results Press Release & Limited Review for Sept 30, 2014 (Standalone)
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE about the Standalone Financial Results, Results Press Release & a copy of the Limited Review Report for the period ended September 30, 2014.14-11-2014